FindTrial
Sign In

Clinical study of pulmonary surfactant treatment for infant moderate to severe acute respiratory distress syndrome

Clinical study of pulmonary surfactant treatment for infant moderate to severe acute respiratory distress syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009213
Enrollment
Unknown
Registered
2016-09-17
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

pulmonary surfactant group:use pulmonary surfactant
Control:Routine treatment

Sponsors

Beijing Children's Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 1 month to 3 years old; 2. Moderate to severe acute respiratory distress syndrome; 3. Clarify the diagnosis in 48 hours .

Exclusion criteria

Exclusion criteria: 1. Corrected gestational age less than 43 weeks; 2. Congenital heart; 3. diseaseChronic lung disease; 4. Tracheal lesion effected extubation,eg tracheostenosis and tracheomalacia; 5. Serious traumatic or anoxic brain injury(GCS<8); 6. Neuromuscular disease.

Design outcomes

Primary

MeasureTime frame
OI;Survival;mechanical ventilation time;—

Countries

China

Contacts

Public ContactKechun Li

Beijing Children's Hospital affiliated to Capital Medical University

kechunli08@163.com+86 15010542179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026